<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="134643">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02116179</url>
  </required_header>
  <id_info>
    <org_study_id>5R34DA031063</org_study_id>
    <secondary_id>5R34DA031063</secondary_id>
    <nct_id>NCT02116179</nct_id>
  </id_info>
  <brief_title>DVD-based HIV/HCV Prevention Intervention for Drug-Involved Latino Criminal Justice Clients</brief_title>
  <official_title>DVD-based HIV/HCV Intervention for Drug-Involved Latino Criminal Justice Clients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Delaware</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Delaware</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <authority>United States: Data Monitoring and Safety Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study are the following: 1) Pilot test and conduct baseline and 3 month
      follow up assessments to evaluate the preliminary efficacy of the DVD-based HIV/HCV
      intervention by randomly assigning 210 Latino corrections-involved, outpatient abuse
      treatment clients to either the experimental intervention or to a wait list control group;
      and 2) to evaluate both participant and interventionist acceptability of this novel
      DVD-based intervention.

      They study hypothesis are the following:

        1. participants in the intervention condition will report greater reductions in sexual
           risk behaviors (e.g., unprotected sexual contact) from baseline to 3 month follow-up
           compared to the control group;

        2. participants will report greater reductions in drug risk behaviors (e.g., sharing
           injection equipment, drug use during sex) from baseline to 3 month follow-up compared
           to the control group;

        3. participants who report more HIV prevention information, motivation, and behavioral
           skills will report fewer sexual risk behaviors.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">May 2015</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Sexual risk behaviors</measure>
    <time_frame>90 days</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Drug Use Behaviors</measure>
    <time_frame>90 days</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Human Immunodeficiency Virus</condition>
  <condition>Acquired Immunodeficiency Syndrome</condition>
  <condition>Hepatitis C</condition>
  <arm_group>
    <arm_group_label>DVD Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>DVD Intervention presented at one 90 minute group session</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wait list Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Group will get no intervention until after 90 day follow up</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>DVD Intervention</intervention_name>
    <description>Participants will be randomly assigned, with a baseline and 3 month follow up assessments</description>
    <arm_group_label>DVD Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  must be between 18 - 49 years of age

          -  self-identify as Hispanic or Latino

          -  be involved in the criminal justice system

          -  report a history of drug use

          -  be in an outpatient substance abuse program

          -  self-identify as heterosexual

        Exclusion Criteria:

          -  be HIV positive

          -  be cognitively impaired
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gladys E Ibanez, PhD</last_name>
    <phone>305-443-2000</phone>
    <email>gibanez@udel.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Steven S Martin, MA</last_name>
    <phone>302-831-1564</phone>
    <email>martin@udel.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Delaware Center for Drug and Alcohol Studies</name>
      <address>
        <city>Coral Gables</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gladys E Ibanez, PhD</last_name>
      <phone>305-443-2000</phone>
      <email>gibanez@udel.edu</email>
    </contact>
    <contact_backup>
      <last_name>Steven S Martin, MA</last_name>
      <phone>302-831-1564</phone>
      <email>martin@udel.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Gladys E Ibanez, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Steven S Martin, MA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 15, 2014</lastchanged_date>
  <firstreceived_date>April 14, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Human Immunodeficiency Virus</keyword>
  <keyword>Acquired Immunodeficiency Syndrome</keyword>
  <keyword>Hepatitis C</keyword>
  <keyword>Hispanic</keyword>
  <keyword>Criminal Justice</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
    <mesh_term>Immunologic Deficiency Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
